These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7838926)

  • 21. Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats.
    Czyrak A; Mogilnicka E; Maj J
    Neuropharmacology; 1989 Mar; 28(3):229-33. PubMed ID: 2725849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diltiazem enhances and flunarizine inhibits nimodipine's antiseizure effects.
    Morón MA; Stevens CW; Yaksh TL
    Eur J Pharmacol; 1989 Apr; 163(2-3):299-307. PubMed ID: 2721577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium channel antagonists attenuate cross-sensitization to the locomotor effects of nicotine and ethanol in mice.
    Biała G; Weglińska B
    Pol J Pharmacol; 2004; 56(4):391-7. PubMed ID: 15520492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of flunarizine and diltiazem on physical dependence on barbital in rats.
    Suzuki T; Mizoguchi H; Noguchi H; Yoshii T; Misawa M
    Pharmacol Biochem Behav; 1993 Jul; 45(3):703-12. PubMed ID: 8392734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine.
    Barrios M; Baeyens JM
    Psychopharmacology (Berl); 1991; 104(3):397-403. PubMed ID: 1718013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cilnidipine, an L/N-type calcium channel blocker prevents acquisition and expression of ethanol-induced locomotor sensitization in mice.
    Bhutada P; Mundhada Y; Patil J; Rahigude A; Zambare K; Deshmukh P; Tanwar D; Jain K
    Neurosci Lett; 2012 Apr; 514(1):91-5. PubMed ID: 22402189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different effect of diltiazem and nifedipine on some central actions of ethanol in the rat.
    Pucilowski O; Krzascik P; Trzaskowska E; Kostowski W
    Alcohol; 1989; 6(2):165-8. PubMed ID: 2713089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dihydropyridines on the components of the ethanol withdrawal syndrome: possible evidence for involvement of potassium, as well as calcium?
    Watson WP; Little JJ
    Alcohol Clin Exp Res; 1997 May; 21(3):409-16. PubMed ID: 9161599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction between benzothiazepine- and dihydropyridine binding sites of cardiac L-type Ca2+ channels.
    Kanda S; Adachi-Akahane S; Nagao T
    Eur J Pharmacol; 1998 Oct; 358(3):277-87. PubMed ID: 9822895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flumazenil (Ro15-1788) does not affect ethanol tolerance and dependence.
    Chan AW; Leong FW; Schanley DL; Langan MC; Penetrante F
    Pharmacol Biochem Behav; 1991 Jul; 39(3):659-63. PubMed ID: 1784594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Action of chlormethiazole in a model of ethanol withdrawal.
    Green AR; Davies EM; Little HJ; Whittington MA; Cross AJ
    Psychopharmacology (Berl); 1990; 102(2):239-42. PubMed ID: 2177205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome.
    Watson WP; Robinson E; Little HJ
    Neuropharmacology; 1997 Oct; 36(10):1369-75. PubMed ID: 9423924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of chronic treatment with the dihydropyridine, Bay K 8644, on hyperexcitability due to ethanol withdrawal, in vivo and in vitro.
    Whittington MA; Butterworth AR; Dolin SJ; Patch TL; Little HJ
    Br J Pharmacol; 1992 Feb; 105(2):285-92. PubMed ID: 1373096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of centrally administered diltiazem on behavioural responses, clinical symptoms, reticulo-ruminal contractions and plasma catecholamine level after experimentally induced duodenal distension in sheep.
    Kania BF; Sutiak V
    Res Vet Sci; 2011 Apr; 90(2):291-7. PubMed ID: 20630549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro.
    Barrios M; Baeyens JM
    Eur J Pharmacol; 1988 Jul; 152(1-2):175-8. PubMed ID: 2463173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
    Atwal KS; Bergey JL; Hedberg A; Moreland S
    J Med Chem; 1987 Apr; 30(4):635-40. PubMed ID: 2435903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury.
    Lipton SA
    Ann Neurol; 1991 Jul; 30(1):110-4. PubMed ID: 1656845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diltiazem inhibits naloxone-precipitated and spontaneous morphine withdrawal in rats.
    Kishioka S; Inoue N; Nishida S; Fukunaga Y; Yamamoto H
    Eur J Pharmacol; 1996 Nov; 316(1):7-14. PubMed ID: 8982643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of L-type calcium channels in the development and expression of behavioral sensitization to ethanol.
    Broadbent J
    Neurosci Lett; 2013 Oct; 553():196-200. PubMed ID: 23994059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.